JPH09510348A - 血行性間葉細胞 - Google Patents

血行性間葉細胞

Info

Publication number: JPH09510348A
Authority: JP; Japan
Prior art keywords: cells; cell; mammalian hematopoietic; fibroblasts; hematogenous
Prior art date: 1994-03-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP7523995A

Other languages

English (en)

Japanese (ja)

Inventor

アントニーセラミ

リチャードジェイブカラ

Original Assignee

ザピコワーインスティテュートフォアメディカルリサーチ

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-16

Filing date

1994-03-16

Publication date

1997-10-21

1994-03-16 Application filed by ザピコワーインスティテュートフォアメディカルリサーチ filed Critical ザピコワーインスティテュートフォアメディカルリサーチ

1997-10-21 Publication of JPH09510348A publication Critical patent/JPH09510348A/ja

Status Pending legal-status Critical Current

Links

208000013210 hematogenous Diseases 0.000 title claims abstract description 47
210000004027 cell Anatomy 0.000 claims abstract description 291
210000002950 fibroblast Anatomy 0.000 claims abstract description 31
230000029663 wound healing Effects 0.000 claims abstract description 21
210000004369 blood Anatomy 0.000 claims abstract description 20
239000008280 blood Substances 0.000 claims abstract description 20
210000005259 peripheral blood Anatomy 0.000 claims abstract description 13
239000011886 peripheral blood Substances 0.000 claims abstract description 13
238000001727 in vivo Methods 0.000 claims abstract description 8
238000000034 method Methods 0.000 claims description 71
108090000623 proteins and genes Proteins 0.000 claims description 49
102000004127 Cytokines Human genes 0.000 claims description 26
108090000695 Cytokines Proteins 0.000 claims description 26
210000003958 hematopoietic stem cell Anatomy 0.000 claims description 23
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 16
230000014509 gene expression Effects 0.000 claims description 10
210000000265 leukocyte Anatomy 0.000 claims description 10
102000008186 Collagen Human genes 0.000 claims description 9
108010035532 Collagen Proteins 0.000 claims description 9
108010065472 Vimentin Proteins 0.000 claims description 9
102000013127 Vimentin Human genes 0.000 claims description 9
229920001436 collagen Polymers 0.000 claims description 9
210000005048 vimentin Anatomy 0.000 claims description 9
102000016359 Fibronectins Human genes 0.000 claims description 8
108010067306 Fibronectins Proteins 0.000 claims description 8
239000000203 mixture Substances 0.000 claims description 7
102000012422 Collagen Type I Human genes 0.000 claims description 6
108010022452 Collagen Type I Proteins 0.000 claims description 6
238000004113 cell culture Methods 0.000 claims description 6
239000003550 marker Substances 0.000 claims description 6
239000000126 substance Substances 0.000 claims description 6
238000004519 manufacturing process Methods 0.000 claims description 5
210000001616 monocyte Anatomy 0.000 claims description 5
210000003719 b-lymphocyte Anatomy 0.000 claims description 4
210000000601 blood cell Anatomy 0.000 claims description 4
230000001747 exhibiting effect Effects 0.000 claims description 4
238000000926 separation method Methods 0.000 claims description 4
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 3
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 3
210000001744 T-lymphocyte Anatomy 0.000 claims description 3
238000000432 density-gradient centrifugation Methods 0.000 claims description 3
239000001963 growth medium Substances 0.000 claims description 3
210000002540 macrophage Anatomy 0.000 claims description 3
238000005406 washing Methods 0.000 claims description 3
239000002458 cell surface marker Substances 0.000 claims description 2
230000000694 effects Effects 0.000 claims description 2
210000005087 mononuclear cell Anatomy 0.000 claims description 2
210000000822 natural killer cell Anatomy 0.000 claims description 2
238000012258 culturing Methods 0.000 claims 7
230000001105 regulatory effect Effects 0.000 claims 2
102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 1
241000124008 Mammalia Species 0.000 claims 1
230000001276 controlling effect Effects 0.000 claims 1
238000011534 incubation Methods 0.000 claims 1
230000001983 lactogenic effect Effects 0.000 claims 1
208000027418 Wounds and injury Diseases 0.000 abstract description 27
206010052428 Wound Diseases 0.000 abstract description 26
238000002955 isolation Methods 0.000 abstract description 11
230000004071 biological effect Effects 0.000 abstract description 6
210000002808 connective tissue Anatomy 0.000 abstract description 6
230000007838 tissue remodeling Effects 0.000 abstract description 6
238000001415 gene therapy Methods 0.000 abstract description 4
238000010171 animal model Methods 0.000 abstract description 3
230000001737 promoting effect Effects 0.000 abstract description 3
230000002324 hematogenic effect Effects 0.000 abstract description 2
210000004962 mammalian cell Anatomy 0.000 abstract 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 22
239000002953 phosphate buffered saline Substances 0.000 description 22
108091003079 Bovine Serum Albumin Proteins 0.000 description 17
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 15
210000001519 tissue Anatomy 0.000 description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
229940098773 bovine serum albumin Drugs 0.000 description 11
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
238000004458 analytical method Methods 0.000 description 9
238000000338 in vitro Methods 0.000 description 8
230000007774 longterm Effects 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
241000699666 Mus <mouse, genus> Species 0.000 description 7
230000008569 process Effects 0.000 description 7
239000000047 product Substances 0.000 description 7
230000035755 proliferation Effects 0.000 description 7
230000004044 response Effects 0.000 description 7
239000000427 antigen Substances 0.000 description 6
102000036639 antigens Human genes 0.000 description 6
108091007433 antigens Proteins 0.000 description 6
239000002609 medium Substances 0.000 description 6
239000012091 fetal bovine serum Substances 0.000 description 5
239000003102 growth factor Substances 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 4
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 4
229930182566 Gentamicin Natural products 0.000 description 4
241000700605 Viruses Species 0.000 description 4
230000001464 adherent effect Effects 0.000 description 4
229960002518 gentamicin Drugs 0.000 description 4
238000010166 immunofluorescence Methods 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
210000004698 lymphocyte Anatomy 0.000 description 4
210000004379 membrane Anatomy 0.000 description 4
239000012528 membrane Substances 0.000 description 4
230000000877 morphologic effect Effects 0.000 description 4
210000000056 organ Anatomy 0.000 description 4
230000008439 repair process Effects 0.000 description 4
230000003248 secreting effect Effects 0.000 description 4
238000012546 transfer Methods 0.000 description 4
241000701161 unidentified adenovirus Species 0.000 description 4
108090001008 Avidin Proteins 0.000 description 3
102000018233 Fibroblast Growth Factor Human genes 0.000 description 3
108050007372 Fibroblast Growth Factor Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 3
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
238000001042 affinity chromatography Methods 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
238000012790 confirmation Methods 0.000 description 3
BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
229940126864 fibroblast growth factor Drugs 0.000 description 3
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
239000012634 fragment Substances 0.000 description 3
239000000499 gel Substances 0.000 description 3
210000004408 hybridoma Anatomy 0.000 description 3
230000010354 integration Effects 0.000 description 3
230000005012 migration Effects 0.000 description 3
238000013508 migration Methods 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
210000000329 smooth muscle myocyte Anatomy 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
238000011282 treatment Methods 0.000 description 3
239000013598 vector Substances 0.000 description 3
230000003442 weekly effect Effects 0.000 description 3
230000037314 wound repair Effects 0.000 description 3
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
241000186216 Corynebacterium Species 0.000 description 2
101710112752 Cytotoxin Proteins 0.000 description 2
108020004414 DNA Proteins 0.000 description 2
YCAGGFXSFQFVQL-UHFFFAOYSA-N Endothion Chemical compound COC1=COC(CSP(=O)(OC)OC)=CC1=O YCAGGFXSFQFVQL-UHFFFAOYSA-N 0.000 description 2
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
206010016654 Fibrosis Diseases 0.000 description 2
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
102000052812 Ornithine decarboxylases Human genes 0.000 description 2
108700005126 Ornithine decarboxylases Proteins 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
208000025865 Ulcer Diseases 0.000 description 2
239000011324 bead Substances 0.000 description 2
238000004166 bioassay Methods 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
238000012136 culture method Methods 0.000 description 2
230000016396 cytokine production Effects 0.000 description 2
231100000599 cytotoxic agent Toxicity 0.000 description 2
239000002619 cytotoxin Substances 0.000 description 2
230000006378 damage Effects 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
238000012137 double-staining Methods 0.000 description 2
VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 2
210000002615 epidermis Anatomy 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
230000004761 fibrosis Effects 0.000 description 2
230000003394 haemopoietic effect Effects 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
208000014674 injury Diseases 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
230000003902 lesion Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
210000000440 neutrophil Anatomy 0.000 description 2
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
239000007787 solid Substances 0.000 description 2
230000010473 stable expression Effects 0.000 description 2
238000010186 staining Methods 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
230000017423 tissue regeneration Effects 0.000 description 2
102000003390 tumor necrosis factor Human genes 0.000 description 2
231100000397 ulcer Toxicity 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
229960001134 von willebrand factor Drugs 0.000 description 2
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
241000701822 Bovine papillomavirus Species 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
208000028006 Corneal injury Diseases 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
108010044052 Desmin Proteins 0.000 description 1
102100036912 Desmin Human genes 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 1
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
-1 III Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
102000007547 Laminin Human genes 0.000 description 1
108010085895 Laminin Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
241001045988 Neogene Species 0.000 description 1
102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
208000001388 Opportunistic Infections Diseases 0.000 description 1
229940122060 Ornithine decarboxylase inhibitor Drugs 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
206010033372 Pain and discomfort Diseases 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
241000700159 Rattus Species 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
206010039710 Scleroderma Diseases 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
230000000735 allogeneic effect Effects 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229940126575 aminoglycoside Drugs 0.000 description 1
230000003367 anti-collagen effect Effects 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
229930185229 antidesmin Natural products 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
238000000149 argon plasma sintering Methods 0.000 description 1
230000003305 autocrine Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
230000008512 biological response Effects 0.000 description 1
230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
239000003710 calcium ionophore Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000012292 cell migration Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000035605 chemotaxis Effects 0.000 description 1
208000019425 cirrhosis of liver Diseases 0.000 description 1
230000035602 clotting Effects 0.000 description 1
230000011382 collagen catabolic process Effects 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000004891 communication Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
210000001608 connective tissue cell Anatomy 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
239000006059 cover glass Substances 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000007123 defense Effects 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
210000005045 desmin Anatomy 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
229960000301 factor viii Drugs 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000000799 fluorescence microscopy Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
101150106093 gpt gene Proteins 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
210000005003 heart tissue Anatomy 0.000 description 1
101150113423 hisD gene Proteins 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
201000008298 histiocytosis Diseases 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
238000007654 immersion Methods 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
238000010185 immunofluorescence analysis Methods 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000004968 inflammatory condition Effects 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
238000001155 isoelectric focusing Methods 0.000 description 1
208000011379 keloid formation Diseases 0.000 description 1
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000002523 lectin Substances 0.000 description 1
210000003041 ligament Anatomy 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
238000007885 magnetic separation Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
230000001617 migratory effect Effects 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
229960000951 mycophenolic acid Drugs 0.000 description 1
206010028537 myelofibrosis Diseases 0.000 description 1
101150091879 neo gene Proteins 0.000 description 1
210000000944 nerve tissue Anatomy 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
230000008520 organization Effects 0.000 description 1
239000002818 ornithine decarboxylase inhibitor Substances 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
150000004633 phorbol derivatives Chemical class 0.000 description 1
239000002644 phorbol ester Substances 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920000447 polyanionic polymer Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
235000010388 propyl gallate Nutrition 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
230000008521 reorganization Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
239000006152 selective media Substances 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000035939 shock Effects 0.000 description 1
229920000260 silastic Polymers 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
101150081616 trpB gene Proteins 0.000 description 1
101150111232 trpB-1 gene Proteins 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
230000002792 vascular Effects 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1
230000009278 visceral effect Effects 0.000 description 1
238000012800 visualization Methods 0.000 description 1
108010047303 von Willebrand Factor Proteins 0.000 description 1
102100036537 von Willebrand factor Human genes 0.000 description 1
210000001325 yolk sac Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Cell Biology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Developmental Biology & Embryology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Medicinal Chemistry (AREA)
General Engineering & Computer Science (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Physics & Mathematics (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Dermatology (AREA)
Pathology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

JP7523995A 1994-03-16 1994-03-16 血行性間葉細胞 Pending JPH09510348A (ja)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1994/002850 WO1995025164A1 (en)	1994-03-16	1994-03-16	Blood-borne mesenchymal cells

Publications (1)

Publication Number	Publication Date
JPH09510348A true JPH09510348A (ja)	1997-10-21

Family

ID=22242354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP7523995A Pending JPH09510348A (ja)	1994-03-16	1994-03-16	血行性間葉細胞

Country Status (5)

Country	Link
EP (1)	EP0759070A4 (de)
JP (1)	JPH09510348A (de)
KR (1)	KR100352057B1 (de)
AU (1)	AU693441B2 (de)
WO (1)	WO1995025164A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1099754A1 (de) *	1999-11-10	2001-05-16	Universiteit Leiden	Mesenchym-Stammzellen und/oder Vorlaüferzellen, ihre Isolierung und ihre Verwendung
WO2011022045A2 (en) *	2009-08-17	2011-02-24	Singh Ashok K	Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use
CN115287260A (zh) *	2022-06-30	2022-11-04	江苏汇先医药技术有限公司	一种t细胞的富集方法

1994
- 1994-03-16 EP EP94913910A patent/EP0759070A4/de not_active Withdrawn
- 1994-03-16 JP JP7523995A patent/JPH09510348A/ja active Pending
- 1994-03-16 AU AU65884/94A patent/AU693441B2/en not_active Ceased
- 1994-03-16 WO PCT/US1994/002850 patent/WO1995025164A1/en not_active Ceased
- 1994-03-16 KR KR1019960705117A patent/KR100352057B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU6588494A (en)	1995-10-03
WO1995025164A1 (en)	1995-09-21
EP0759070A1 (de)	1997-02-26
KR970701777A (ko)	1997-04-12
EP0759070A4 (de)	1998-03-11
KR100352057B1 (ko)	2003-01-24
AU693441B2 (en)	1998-07-02

Legal Events

Date	Code	Title	Description
2004-01-29	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040105
2004-03-02	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040302 Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040302
2004-07-01	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040630
2004-08-12	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040811
2004-09-01	A911	Transfer to examiner for re-examination before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040902
2004-09-28	A912	Re-examination (zenchi) completed and case transferred to appeal board	Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20040922

Publication	Publication Date	Title
US6174526B1 (en)	2001-01-16	Blood-borne mesenchymal cells
US5804446A (en)	1998-09-08	Blood-borne mesenchymal cells
US6054121A (en)	2000-04-25	Modulation of immune responses in blood-borne mesenchymal cells
JP4767983B2 (ja)	2011-09-07	骨髄に由来するＴＧＦβ１応答細胞
US20090035282A1 (en)	2009-02-05	Pluripotent embryonic-like stem cells derived from teeth and uses thereof
CN110914410A (zh)	2020-03-24	γδT细胞扩增、组合物及其使用方法
JP2002517227A (ja)	2002-06-18	造血幹細胞の試験管内維持
JP2002537761A (ja)	2002-11-12	トランスジェニック循環内皮細胞
EP1876233A1 (de)	2008-01-09	Zur differenzierung in herzmuskelzellen fähige zellen
JP2002529509A (ja)	2002-09-10	ヒト間葉幹細胞の子宮内移植で胎児を処置し間葉幹細胞を移植し移植器官を調製する方法と調製された雑種器官
CN116987199A (zh)	2023-11-03	表达靶向fap的嵌合抗原受体巨噬细胞及其构建方法和应用
Bucala	2007	Fibrocytes: new insights into tissue repair and systemic fibroses
JPH09510348A (ja)	1997-10-21	血行性間葉細胞
JP5097387B2 (ja)	2012-12-12	人工皮膚
CN116966301B (zh)	2026-01-09	Fap蛋白在制备抑制或清除衰老细胞试剂上的用途
WO2002097066A2 (en)	2002-12-05	Human vascular progenitor cells
CN119563020A (zh)	2025-03-04	经低温保存的中间体以及用于其的效力测定
NZ265435A (en)	1998-05-27	Blood-borne mesenchymal cells (fibroblasts) for wound healing and tissue remodelling
CA2185539A1 (en)	1995-09-21	Blood-borne mesenchymal cells
CN1088105C (zh)	2002-07-24	血液携带的间质细胞
CA2449466A1 (en)	2002-12-12	Peripheral blood fibrocytes differentiation pathway and migration to wound sites
US20030219416A1 (en)	2003-11-27	Long-lived keratinocytes
WO2024128224A1 (ja)	2024-06-20	間葉系幹細胞の脂肪細胞への分化能を増幅させるための組成物
KR20250145615A (ko)	2025-10-13	효력 검정 및 제조 방법
CN118370827A (zh)	2024-07-23	降低aibp蛋白表达在促进侧支循环上的应用